Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high1,187.0 01/11/17
52 week low751.5 23/03/17
52 week change 198.0 (23.43%)
4 week volume6,423,525 28/01/18
price1,043.0
price date1519387984
close1,054.0

Latest NewsMore

Notice of Results

RNS Number: 0247E Clinigen Group plc 06 February 2018 6 February 2018 Notification of half year results date Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global pharmaceutical and services company, will announce its half year results for the six months ended 31 December 2017 on Tuesday, 27 February 2018. A group analyst briefing will be held ...

Broker Forecast - Berenberg issues a broker note on Clinigen Group

Berenberg today upgrades its investment rating on Clinigen Group (LON:CLIN) to buy (from hold) and raised its price tar...

Broker Forecast - Numis issues a broker note on Clinigen Group

Numis today reaffirms its add investment rating on Clinigen Group (LON:CLIN) and set its price target at 1208p.

Clinigen revenues up 28% in first half

Global pharmaceutical and services company Clinigen said it traded well in the first half to the end of December and in li...

HY trading update

RNS Number: 0600C Clinigen Group plc 17 January 2018 17 January 2018 HY trading update: good H1 performance with profits up over 10% Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, today provides a trading update for the six months ended 31 December 2017. The Group has traded well in the first half...

Total Voting Rights

RNS Number: 9389Z Clinigen Group plc 29 December 2017 29 December 2017 Clinigen Group plc ("Clinigen" or the "Group") Total Voting Rights and Capital In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Group notifies the market that as at 29 December 2017 Clinigen's issued share capital consists of 122,286,083 ordinary shares...

Clinigen director steps down

Clinigen Group director Chris Rigg has resigned with immediate effect to seek a chief executive role elsewhere. Clinigen CE...

Directorate Change

RNS Number: 4871Y Clinigen Group plc 06 December 2017 6 December 2017 Directorate Change Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere. Shaun Chilton, CEO of Clinigen, said: "On behalf of the B...

Fundamental DataMore

P/E ratio316.061
EPS3.3
Dividend yield0.479 %

Latest discussion posts More

  • Any Views Anyone

    Trading update Wednesday Great sign stock falling ( NOT ) INMO quantum holders were sold short with strike price over eleven pounds.. INMO the results will show a high ...
    15-Jan-2018
    up protherics
  • The Times

    Over the weekend the Times carried an article about how the market in unlicensed medicines had grown Personally I think this could be either a positive or negative depending ...
    2-Jan-2018
    up protherics
  • Todays RNS

    HMMMMmmmmmm ??? I am lost for words Why wasn't he made to stay... Either they realised that he would be an overpaid director doing practically nothing.. Alternatively ...
    6-Dec-2017
    up protherics

Users' HoldingsMore

Users who hold Clinigen Group also hold..

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account